1. IL-32α-induced inflammation constitutes a link between obesity and colon cancer
   Victoria Catalán et al, 2017, OncoImmunology CrossRef
2. Interleukin-32 induced thymic stromal lymphopoietin plays a critical role in the inflammatory response in human corneal epithelium
   Jing Lin et al, 2018, Cellular Signalling CrossRef
3. Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease
   Julie V. Philley et al, 2018, Sci Rep CrossRef
4. Natural killer cells and tumor metastasis
   Hwan Hee Lee et al, 2017, Arch. Pharm. Res. CrossRef
5. Intracellular Alarmins: Hidden dangers signals crucial for cancer, host defense and inflammatory processes
   Leo A.B. Joosten et al, 2018, Seminars in Immunology CrossRef
6. Interleukin 32 expression in human melanoma
   Helicia Paz et al, 2019, J Transl Med CrossRef
7. Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray
   null Alshabi et al, 2019, Biomolecules CrossRef
8. Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large-scale and targeted quantitative proteomics.
   Mariette Matondo et al, 2017, Proteomics CrossRef
9. Interleukin 32, inflammation and cancer
   Jin Tae Hong et al, 2017, Pharmacology & Therapeutics CrossRef
10. MicroRNA‐29b‐3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway
    Jianya He et al, 2019, J Cell Mol Med CrossRef
11. Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer
    Rosa Mistica C. Ignacio et al, 2019, Oncotarget CrossRef
12. IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production
    Man Sub Kim et al, 2015, Oncotarget CrossRef
13. Role of interleukin‑32 in cancer biology (Review)
    Haimeng Yan et al, 2018, Oncol Lett CrossRef
14. IL‑32 expression indicates unfavorable prognosis in patients with colon cancer
    Jing‑Ming Zhai et al, 2019, Oncol Lett CrossRef
15. Molecular interactions and functions of IL‐32
    Kristin Roseth Aass et al, 2020, J Leukoc Biol CrossRef
16. Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance
    Dorota Diakowska et al, 2020, Diagnostics CrossRef
17. The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies
    Giovanni Zarrilli et al, 2020, IJMS CrossRef
18. The role of Interleukin‐32 in autoimmunity
    Rafael Albuquerque et al, 2021, Scand J Immunol CrossRef
19. Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression
    Jing Jin et al, 2021, Cell Commun Signal CrossRef
20. Prognostic Value of Interleukin-32 Expression and Its Correlation with the Infiltration of Natural Killer Cells in Cutaneous Melanoma
    Ji Young Kang et al, 2021, JCM CrossRef
21. A Paradoxical Effect of Interleukin-32 Isoforms on Cancer.
    Saerok Shim et al, 2022, Front Immunol CrossRef
22. null
    Md. Abdul Aziz et al, 2022 CrossRef
23. Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8
    Muneo Numasaki et al, 2022, Cellular Immunology CrossRef
24. Hematological and Biochemical Responses of Newly Formulated Primary Root Canal Obturating Material: An In Vivo Study.
    Prasanna T Dahake et al, 2022, Cureus CrossRef
25. A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas
    Shulian Zeng et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
26. IL-32 and its Paradoxical Role in Neoplasia
    Jacob T. Hough et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
27. STATs signaling pathways in dendritic cells: As potential therapeutic targets?
    Sepideh Sohrabi et al, 2023, International Reviews of Immunology CrossRef
28. Role of interleukin‑32 in cancer progression (Review)
    Danyang Meng et al, 2023, Oncol Lett CrossRef
29. Pan-cancer analysis reveals IL32 is a potential prognostic and immunotherapeutic biomarker in cancer
    Feng Han et al, 2024, Sci Rep CrossRef